Description

Tirzepatide is a dual GLP 1 and GIP receptor agonist researched extensively within metabolic and endocrine science. Studies investigate its interaction with both receptor pathways and their relationship with glucose regulation, energy metabolism, and body composition. The dual receptor profile makes Tirzepatide a valuable compound for research examining how interconnected incretin signalling pathways influence metabolic processes under controlled experimental conditions. Researchers continue to investigate its broader biological mechanisms and metabolic signalling characteristics. This formulation contains 10mg across 10 vials and is supplied for controlled laboratory research into GLP 1 and GIP receptor activity, metabolic pathways, glucose regulation, and related biological processes.